UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): January 27, 2021
CORELOGIC, INC.
(Exact Name of the Registrant as Specified in Charter)
| Delaware | 001-13585 | 95-1068610 | ||
(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
| 40 Pacifica | Irvine | California | 92618-7471 | |||
| (Street Address) | (City) | (State) | (Zip Code) |
Registrant’s telephone number, including area code (949) 214-1000
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class: | Trading symbol(s) | Name of exchange on which registered | ||
| Common Stock, $0.00001 par value | CLGX | New York Stock Exchange | ||
| Preferred Stock Purchase Rights | CLGX | New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 5.03 | Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. |
The disclosure under Item 8.01 of this current report on Form 8-K is incorporated by reference.
| Item 8.01 | Other Events. |
On January 27, 2021, the Board of Directors (the “Board”) of CoreLogic, Inc., a Delaware corporation (the “Company”), extended the deadline for stockholders to nominate directors for election to the Board and propose other business for consideration at the Company’s 2021 annual meeting of stockholders (the “2021 Annual Meeting”) from January 28, 2021 to February 12, 2021. Director nominations and proposals of other business submitted at or prior to the close of business on February 12, 2021 that otherwise comply with the Company’s Amended and Restated Bylaws and applicable law will be considered timely. This waiver and extension of the advance notice deadline is applicable only for the 2021 Annual Meeting.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: January 27, 2021
| CORELOGIC, INC. | ||
| By: | /s/ Frank D. Martell | |
| Name: | Frank D. Martell | |
| Title: | President and Chief Executive Officer | |